Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Decavit Plus
- Development stage
- Unknown
- Lead developer
- Rowa
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Decavit Plus is a comprehensive multivitamin and multimineral food supplement developed and marketed by Rowa Pharmaceuticals. It is formulated to provide a broad spectrum of essential micronutrients, including vitamins A, C, D, E, and the B-complex series, alongside key minerals such as iron, zinc, magnesium, and calcium. The product is designed to support overall health, immune function, and energy metabolism by addressing potential nutritional gaps in the diet. As a food supplement, it is primarily indicated for general nutritional supplementation and the prevention of vitamin and mineral deficiencies.
- Brand names
- Decavit Plus
02
Targets
RAR (Retinoic acid receptor)VDR (Vitamin D receptor)
Beyond the preview
Go deeper on Decavit Plus.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Decavit Plus.